1. |
Novel HIV-1 therapies needed |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
2. |
The NCI*and the US FDA are collaborating on a cancer drug development programme, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
3. |
Substance abuse comorbidity among patients with psychiatric disorders is associated with a considerable increase in the use of hospital emergency-department (ED) services, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
4. |
An eye for cost-effective drugs cuts costs in glaucoma |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 5-6
L Hunt,
Preview
|
|
摘要:
Glaucoma is an eye condition characterised by intraocular pressure (IOP) in one or both eyes. In order to prevent the progression to visual field loss, IOP should be reduced. Several posters presented at the 8th International Meeting of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) [Arlington, US; May 2003] evaluated the cost effectiveness of various therapies for treating glaucoma. All of the presentations were funded by Allergan, Inc., US.1,2,3,4
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
5. |
Immunotherapeutic vaccine for Hodgkin's disease and NPC |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
6. |
PT-100*improves severe neutropenia associated with chemotherapy, |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
7. |
SARS: seeking a real-time solution |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 9-11
T Wright,
RM Poole,
Preview
|
|
摘要:
The outbreak of Severe Acute Respiratory Syndrome (SARS) clearly illustrates that the emergence or re-emergence of infectious diseases is a constant threat. In late February, the world became aware of the existence of SARS in Vietnam after an alert from WHO scientist Dr Carlo Urbani (who later died from the disease). However, SARS originated in southern China in November 2002. Globally, the total number of confirmed cases has now reached 8221 (as at 27 May 2003). While patients with SARS have been identified in more than 30 countries, the majority of cases have occurred in China (7648), including Hong Kong (1728) and Taiwan (596). To date, control of the SARS outbreak has focused on preventing its transmission, and there has been an emphasis on the development of diagnostic tests to accurately identify the virus in patients with suspected SARS infections. However, a number of compounds are currently under investigation as potential treatments for the disease.
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
8. |
Amodiaquine reduces malarial fevers, anaemia in infants |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
9. |
Amoxicillin/clavulanic acid for paediatric febrile neutropenia |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|
10. |
Rosiglitazone improves insulin sensitivity, steatosis in NASH |
|
Inpharma Weekly,
Volume &NA;,
Issue 1390,
2003,
Page 13-13
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2003
数据来源: ADIS
|